검색어 : 통합검색[Snell Keith.]
총 107건 중 107건 출력
, 10/11 페이지
-
91
- The genetic organization and protein crystallographic structure of human serine hydroxymethyltransferase
- Snell, Keith; Baumann, Ulrich; Byrne, Paula C; Chave, Karen J; Renwick, Suzanne B; Sanders, Peter G; Whitehouse, Suzanna K; ; (Advances in enzyme regulation, v.40, 2000, pp.353-403)
-
92
- Book reviews
- ; ; (The Economic history review, v.45, 1992, pp.794-847)
-
93
- Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase
- Mol, Clifford D.; Dougan, Douglas R.; Schneider, Thomas R.; Skene, Robert J.; Kraus, Michelle L.; Scheibe, Daniel N.; Snell, Gyorgy P.; Zou, Hua; Sang, Bi-Ching; Wilson, Keith P.; ; (The Journal of biological chemistry, v.279, 2004, pp.31655-31663)
-
94
- Entrustment Decision Making in Clinical Training :
- ten Cate, Olle; Hart, Danielle; Ankel, Felix; Busari, Jamiu; Englander, Robert; Glasgow, Nicholas; Holmboe, Eric; Iobst, William; Lovell, Elise; Snell, Linda S.; Touchie, Claire; Van Melle, Elaine; Wycliffe-Jones, Keith; ; (Academic medicine : journal of the Association of American Medical Colleges, v.91, 2016, pp.191-198)
-
95
- Whole Genome Phylogenetic Tree Reconstruction Using Colored de Bruijn Graphs
- Lyman, Cole A.; Fujimoto, M. Stanley; Suvorov, Anton; Bodily, Paul M.; Snell, Quinn; Crandall, Keith A.; Bybee, Seth M.; Clement, Mark J.; ; (Bioinformatics and Bioengineering (BIBE), 2017 IEEE 17th International Conference on, v.2017, 2017, pp.260-265)
-
96
- <i>Pathoscope</i>: Species identification and strain attribution with unassembled sequencing data
- Francis, Owen E.; Bendall, Matthew; Manimaran, Solaiappan; Hong, Changjin; Clement, Nathan L.; Castro-Nallar, Eduardo; Snell, Quinn; Schaalje, G. Bruce; Clement, Mark J.; Crandall, Keith A.; Johnson, W. Evan; Department of Statistics, Brigham Young University, Provo, Utah 84602, USA; ; Department of Biology, Brigham Young University, Provo, Utah 84602, USA; ; Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA; ; Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA; ; Department of Computer Science, Brigham Young University, Provo, Utah 84602, USA; ; Computational Biology Institute, George Washington University, Ashburn, Virginia 20147, USA; Department of Computer Science, Brigham Young University, Provo, Utah 84602, USA; ; Department of Statistics, Brigham Young University, Provo, Utah 84602, USA; ; Department of Computer Science, Brigham Young University, Provo, Utah 84602, USA; ; Computational Biology Institute, George Washington University, Ashburn, Virginia 20147, USA; Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts 0211; (Genome research, v.23, 2013, pp.1721-1729)
-
97
- Eleven Years On: A Clinical Update of Key Areas of the 1996 Lung Allograft Rejection Working Formulation
- Snell, Gregory I.; Boehler, Annette; Glanville, Allan R.; McNeil, Keith; Scott, John P.; Studer, Sean M.; Wallwork, John; Westall, Glen; Zamora, Martin R.; Stewart, Susan; ; (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, v.26, 2007, pp.423-430)
-
98
- Feasibility of Concussion Rehabilitation Approaches Tailored to Psychological Coping Styles: A Randomized Controlled Trial
- Silverberg, Noah D.; Cairncross, Molly; Brasher, Penelope M.A.; Vranceanu, Ana-Maria; Snell, Deborah L.; Yeates, Keith Owen; Panenka, William J.; Iverson, Grant L.; Debert, Chantel T.; Bayley, Mark T.; Hunt, Cindy; Baker, Andrew; Burke, Matthew J.; ; (Archives of physical medicine and rehabilitation, v.103, 2022, pp.1565-1573.e2)
-
99
- Graded Exposure Therapy for Fear Avoidance Behaviour After Concussion (GET FAB): protocol for a multisite Canadian randomised controlled trial
- Mikolic, Ana; Klotz, Tasha; Brasher, Penelope; Yeates, Keith; Vranceanu, Ana-Maria; Kendall, Karen D; Snell, Deborah L; Debert, Chantel T; Bayley, Mark; Panenka, William; Cairncross, Molly; Hunt, Cindy; Burke, Matthew; Tartaglia, Maria Carmela; Silverberg, Noah; Department of Psychology, The University of British Columbia, Vancouver, British Columbia, Canada; Department of Psychology, The University of British Columbia, Vancouver, British Columbia, Canada; Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada; Department of Psychology, University of Calgary, Calgary, Alberta, Canada; Department of Psychiatry, Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital, Boston, Massachusetts, USA; School of Kinesiology, Acadia University, Wolfville, Nova Scotia, Canada; Department of Orthopedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch, New Zealand; Alberta Children's Hospital Research Institute, Univeristy of Calgary, Calgary, Alberta, Canada; Hull-Ellis Concussion Clinic, Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, UBC, Vancouver, Bri; (BMJ open, v.14, 2024, pp.e086602-e086602)
-
100
- Comparison of an FAP-targeted, CD137 activating DARPin drug candidate with a non-targeted, CD137 activating antibody in a human PBMC transplanted HT-29 mouse tumor model.
- Hepp, Julia; Link, Alexander; Fiedler, Ulrike; Reichen, Christian; Metz, Clara; Titz, Alexander; Tosevski, Ivana; Juglair, Laurent; Schildknecht, Patricia; Kaufmann, Yvonne; Fontaine, Simon; Bessey, Ralph; Arany, Zita; Zitt, Christof; Dawson, Keith M.; Steiner, Daniel; Snell, Dan; Levitsky, Victor; Stumpp, Michael T.; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzerland; ; Molecular Partners AG, Zurich-Schlieren, Switzer; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.35, 2017, pp.e14626-e14626)
QUICK MENU
